AbbVie Reports First-Quarter 2018 Financial Results

NORTH CHICAGO, Ill., April 26, 2018 /PRNewswire/ -- AbbVie (NYSE:ABBV) announced financial results for the first quarter ended March 31, 2018.

Shedding a Light on the Plight of Street Children

The Consortium for Street Children inspires volunteers to fight for those whose rights – and lives – are too often ignored.

Science Rocks! Seeing Alzheimer’s Disease More Clearly

For the first time, researchers have visualized in detail two types of tau protein fibers, which are offering a deeper understanding of Alzheimer’s disease.

Five Things People Get Wrong about Endometriosis

Three advocates for endometriosis awareness and education share the top myths they think need to be debunked.

What Makes the Immune System Compromise Your Health?

Janus kinase (JAK) enzymes can be responsible for inappropriate activation of immune cells that play a critical role in autoimmune disorders.

The Blueprint of You: Unlocking the Potential of Whole Genome Sequencing

A genetic pioneer reveals what he learned from mapping his own genome.

Helping Young Scientists Become Their Own Role Models

Through a unique partnership with Asian University for Women, scientists inspire students across the world see into their futures.

Science Rocks! The Science Behind the Scent of Some Diseases

With the help of super smellers, scientists are studying certain chemicals that may change a patient’s scent.

AbbVie Recognized as a FORTUNE 100 Best Company to Work For

AbbVie makes the FORTUNE 100 Best Companies to Work For list for the first time.

Transforming Pediatric Cancer Care From the Ground Up

A long-term partnership evolves to meet the unexpected challenges of a pediatric oncology ward in Malawi.